Pancreatic carcinoma is a common pancreatic tumor. It is a highly malignant digestive tract tumor that is difficult to diagnose and treat. About 90% of pancreatic cancers are ductal adenocarcinomas that originate from the glandular duct epithelium. Its morbidity and mortality rates have increased significantly in recent years. The 5-year survival rate is less than 1%, making it one of the malignant tumors with the worst prognosis. The early diagnosis rate of pancreatic cancer is not high, the surgical mortality rate is high, and the cure rate is very low. The incidence of this disease is higher in men than in women, with a male-to-female ratio of 1.5 to 2:1. Male patients are much more common than premenopausal women, and the incidence rate of postmenopausal women is similar to that of men.